{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:25:10Z","timestamp":1792016710072,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.jns.2004.09.018","type":"journal-article","created":{"date-parts":[[2004,10,12]],"date-time":"2004-10-12T16:41:28Z","timestamp":1097599288000},"page":"63-66","source":"Crossref","is-referenced-by-count":55,"title":["Treatment of vascular dementia\u2014evidence from clinical trials with cholinesterase inhibitors"],"prefix":"10.1016","volume":"226","author":[{"given":"Timo","family":"Erkinjuntti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2004.09.018_bib1","first-page":"658","article-title":"Neuropathologic substrates of ischemic vascular dementia","volume":"60","author":"Vinters","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jns.2004.09.018_bib2","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1093\/brain\/121.12.2249","article-title":"Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain","volume":"121","author":"Selden","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.jns.2004.09.018_bib3","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1212\/01.WNL.0000055927.22611.EB","article-title":"Cholinergic denervation in a pure multi-infarct state: observations on CADASIL","volume":"60","author":"Mesulam","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2004.09.018_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0304-3940(94)90854-0","article-title":"Neurochemical profiles in cerebrospinal fluid of stroke-prone spontaneously hypertensive rat","volume":"166","author":"Togashi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jns.2004.09.018_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000142920","article-title":"A comparative histochemical mapping of the distribution of butrylcholinesterase in the brains of four species of animals, including man","volume":"66","author":"Freidle","year":"1967","journal-title":"Acta Anat (Basel)"},{"key":"10.1016\/j.jns.2004.09.018_bib6","series-title":"Vascular cognitive impairment","first-page":"167","article-title":"Neurotransmitter control of the cerebral vasculature and abnormalities in vascular dementia","author":"Court","year":"2002"},{"key":"10.1016\/j.jns.2004.09.018_bib7","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/gps.496","article-title":"Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success ?","volume":"16","author":"Winblad","year":"2001","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jns.2004.09.018_bib8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1749-6632.2002.tb04859.x","article-title":"The Donepezil VaD 307 and 308 Study Groups. Donepezil-treated patients with probable vascular dementia demonstrate cognitive benefits","volume":"977","author":"Pratt","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jns.2004.09.018_bib9","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/01.STR.0000091396.95360.E1","article-title":"Efficacy and tolerability of donepezil in vascular dementia. Positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial","volume":"34","author":"Black","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2004.09.018_bib10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/01.WNL.0000078943.50032.FC","article-title":"Donepezil in vascular dementia. A randomized, placebo-controlled study","volume":"61","author":"Wilkinson","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2004.09.018_bib11","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Work Group","volume":"43","author":"Rom\u00e1n","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2004.09.018_bib12","first-page":"1283","article-title":"Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial","volume":"359","author":"Erkinjuntti","year":"2002","journal-title":"J. Am. Geriatr. Soc."},{"issue":"7","key":"10.1016\/j.jns.2004.09.018_bib13","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2004.09.018_bib14","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0149-2918(03)80168-6","article-title":"An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia","volume":"25","author":"Erkinjuntti","year":"2003","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jns.2004.09.018_bib15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2165\/00023210-200317120-00004","article-title":"Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease","volume":"17","author":"Small","year":"2003","journal-title":"CNS Drugs"},{"issue":"Suppl. 178","key":"10.1016\/j.jns.2004.09.018_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1034\/j.1600-0404.106.s178.4.x","article-title":"Cognitive decline and treatment options for patients with vascular dementia","volume":"106","author":"Erkinjuntti","year":"2002","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2004.09.018_bib17","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1046\/j.1468-1331.2003.00677.x","article-title":"Long-term safety and cognitive effects of galantamine in the treatment of probable vascular dementia or Alzheimer's disease with cerebrovascular disease","volume":"10","author":"Kurz","year":"2003","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2004.09.018_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1468-1331.2001.00224.x","article-title":"Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow-up","volume":"8","author":"Moretti","year":"2001","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2004.09.018_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-510X(02)00280-0","article-title":"Rivastigmine in subcortical vascular dementia: an open 22-month study","volume":"203","author":"Moretti","year":"2002","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2004.09.018_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1468-1331.2000.00046.x","article-title":"An efficacy and safety analysis of Exelon in Alzheimer's disease with concurrent vascular risk factors","volume":"7","author":"Kumar","year":"2000","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2004.09.018_bib21","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1742-1241.2002.tb11377.x","article-title":"Rivastigmine in patients with Alzheimer's disease and concurrent hypertension","volume":"56","author":"Erkinjuntti","year":"2002","journal-title":"Int. J. Clin. Pract."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X04002953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X04002953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T14:49:03Z","timestamp":1682779743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X04002953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":21,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0022510X04002953"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2004.09.018","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}